Dr. Eleonora Ford currently serves as a Director of Global Regulatory and R&D Policy at Amgen, with a focus on the United States. She joined Amgen in 2005, where she spent over ten years in Global Scientific Communications, Global Scientific Affairs leading Payer, Value & Formulary and compendia activities focused on communicating scientific information to U.S. payers and formulary decision-makers in support of all Amgen products and biosimilars. Dr. Ford received her Ph.D. in Chemistry from King’s College London UK, carrying out the majority of her research at the Gray Cancer Institute in the UK. Subsequently, she served as a postdoctoral researcher in the Pharmacology Department at the University of California, Los Angeles.